Foxx Life Sciences Adds New Asia Headquarters in India
Foxx Life Sciences announce new Asia headquarters in India.
In a recent press release (1), Foxx Life Sciences announced that their custom single-use systems (SUS) company will be opening their new international Asia headquarters in Medchal, Hyderabad, India. With this new location, Foxx will bring continued expansion of biopharmaceutical manufacturing to the region.
"Foxx is proud to expand in Asia to offer innovative products to the Indian and Asian markets,” said Vikram Mahapatra, vice president of Foxx Life Sciences (1). “We are happy to be committed to providing our customers with high-quality products with exceptional global customer service.”
Foxx Life Sciences will maintain its initiative to invest in the strong demand growth forecasted in the India and Asia markets for Foxx Custom (SUT), which is specifically designed to support biopharmaceutical and bioprocess companies.
Following the addition of Foxx Life Sciences new facility, they launched a new website, https://www.foxxlifesciences.in, regarding product knowledge and online purchasing of their products for Asia customers.
"Foxx is recognized as the bridge to India in the USA" stated Thomas Taylor, President and CEO.
The new headquarters will also include warehouse inventory and manufacturing for the Asian-Pacific region.
Reference
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
